Feng T, Li W, Wang Q, Yang J, Shen F. Global, regional, and national burden of uterine cancer among women aged 50 years and older from 1990 to 2021: a systematic analysis for the global burden of disease study 2021. J Health Popul Nutr. 2025;44(1):208.

Article  PubMed  PubMed Central  Google Scholar 

KARŁOWICZ K, HERMANOWSKA M, LUBOMIRSKA J, FIGUROWSKA P, CIULKIEWICZ Ł. Role of metabolic syndrome and lifestyle factors in endometrial cancer risk and prevention. 2024.

Salmon A, Lebeau A, Streel S, Dheur A, Schoenen S, Goffin F, et al. Locally advanced and metastatic endometrial cancer: Current and emerging therapies. Cancer Treat Rev. 2024;129:102790.

Article  CAS  PubMed  Google Scholar 

Rubinstein M, Shen S, Monk BJ, Tan DS, Nogueira-Rodrigues A, Aoki D, et al. Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer. Gynecol Oncol. 2022;167(3):540–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levine DA, Getz G, Gabriel SB, Cibulskis K, Lander E, Sivachenko A, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73. https://doi.org/10.1038/nature12113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Z, Yang X, Liu X, Ma K, Meng Y-T, Yin H-F, et al. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols. BMC Cancer. 2023;23(1):243.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73.

Article  PubMed  PubMed Central  Google Scholar 

Balhara N, Yadav R, Chauhan MB. Role of signaling pathways in endometrial cancer. Mol Biol Rep. 2025;52(1):408.

Article  CAS  PubMed  Google Scholar 

Shiozaki T, Westin SN. Targeted Therapy and Prevention of Endometrial Cancer. Precision Mol Pathol Uterine Cancer. 2017:187–223.

Wang H, Zhang K, Liu J, Yang J, Tian Y, Yang C, et al. Curcumin regulates cancer progression: Focus on ncRNAs and molecular signaling pathways. Front Oncol. 2021;11:660712.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jahanbakhshi F, Maleki Dana P, Badehnoosh B, Yousefi B, Mansournia MA, Jahanshahi M, et al. Curcumin anti-tumor effects on endometrial cancer with focus on its molecular targets. Cancer Cell Int. 2021;21(1):120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Z, Yi P, Tu C, Zhan J, Jiang L, Zhang F. Curcumin inhibits ERK/c-Jun expressions and phosphorylation against endometrial carcinoma. Biomed Res Int. 2019;2019(1):8912961.

PubMed  PubMed Central  Google Scholar 

Xu Y-X, Pu S-D, Li X, Yu Z-W, Zhang Y-T, Tong X-W, et al. Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications. Pharmacol Res. 2022;178:106135.

Article  CAS  PubMed  Google Scholar 

Sohn S-I, Priya A, Balasubramaniam B, Muthuramalingam P, Sivasankar C, Selvaraj A, et al. Biomedical applications and bioavailability of curcumin—An updated overview. Pharmaceutics. 2021;13(12):2102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mundekkad D, Cho WC. Applications of curcumin and its nanoforms in the treatment of cancer. Pharmaceutics. 2023;15(9):2223.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yakubu J, Pandey AV. Innovative delivery systems for curcumin: Exploring nanosized and conventional formulations. Pharmaceutics. 2024;16(5):637.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zahid A, Khurshid A, Rehman SU, Hassan SMU, Akhtar R. Enhanced intracellular delivery of curcumin using polymeric nanocarriers: a natural photosensitizing agent for anti-cancer photodynamic therapy. J Fluoresc. 2025:1–13.

Talebi M, Shahbazi K, Dakkali MS, Akbari M, Ghale RA, Hashemi S et al. Phytosomes: A promising nanocarrier system for enhanced bioavailability and therapeutic efficacy of herbal products. Phytomedicine Plus. 2025:100779.

Hocking AJ, Farrall AL, Newhouse S, Sordillo P, Greco K, Karapetis CS, et al. Study protocol of a phase 1 clinical trial establishing the safety of intrapleural administration of liposomal curcumin: curcumin as a palliative treatment for malignant pleural effusion (IPAL-MPE). BMJ open. 2021;11(3):e047075.

Article  PubMed  PubMed Central  Google Scholar 

Khosravi MA, Seifert R. Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(5):3477–91.

Article  CAS  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372.

Chen Q, Gao Q, Chen K, Wang Y, Chen L, Li X. Curcumin suppresses migration and invasion of human endometrial carcinoma cells. Oncol Lett. 2015;10(3):1297–302.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yilmaz E, Melekoglu R, Ciftci O, Eraslan S, Cetin A, Basak N. The therapeutic effects of curcumin and capsaicin against cyclophosphamide side effects on the uterus in rats. Acta cirurgica brasileira. 2018;33(06):499–507.

Article  PubMed  Google Scholar 

Sun M-X, Yu F, Gong M-L, Fan G-L, Liu C-X. Effects of curcumin on the role of MMP-2 in endometrial cancer cell proliferation and invasion. European Review for Medical & Pharmacological Sciences. 2018;22(15).

Xu H, Gong Z, Zhou S, Yang S, Wang D, Chen X, et al. Liposomal curcumin targeting endometrial cancer through the NF-κB pathway. Cell Physiol Biochem. 2018;48(2):569–82.

Article  CAS  PubMed  Google Scholar 

Tuyaerts S, Rombauts K, Everaert T, Van Nuffel AM, Amant F. A phase 2 study to assess the immunomodulatory capacity of a lecithin-based delivery system of curcumin in endometrial cancer. Front Nutr. 2019;5:138.

Article  PubMed  PubMed Central  Google Scholar 

Manuaba IF, editor. Curcumin as an Alternative Medicine for Terminal Stage Endometrial Cancer Patient (Case Report). 4th International Symposium on Health Research (ISHR 2019); 2020: Atlantis Press.

Li J. Curcumin Inhibits the Growth and Induces Apoptosis of Human Endometrial Cancer Cells. Indian J Pharm Sci. 2022;84(6).

Yan F, Wang Y, Chen L, Cheng W, Oduro-Kwateng E, Soliman ME, et al. Nanohydrogel of Curcumin/Berberine Co‐Crystals Induces Apoptosis via Dual Covalent/Noncovalent Inhibition of Caspases in Endometrial Cancer Cell Lines: The Synergy Between Pharmacokinetics and Pharmacodynamics. J Mol Recognit. 2025;38(2):e70004.

Article  CAS  PubMed  PubMed Central  Google Scholar